Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Cardiotoxicity × Palliative Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 18 Neoplasms 10 Ovarian Neoplasms 6 Lung Neoplasms 6 Leukemia, Myeloid, Acute 6 Multiple Myeloma 5 Lymphoma 5 Hematologic Neoplasms 5 Prostatic Neoplasms 4 Neoplasm Metastasis 4 Leukemia 4 Fatigue 4 Colorectal Neoplasms 4 Vulvar Neoplasms 3 Uterine Cervical Neoplasms 3 Pancreatic Neoplasms 3 Myelodysplastic Syndromes 3 Depression 3 Anxiety Disorders 3 Vaginal Neoplasms 2 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Sarcoma 2 Peritoneal Neoplasms 2 Glioblastoma 2 Genital Neoplasms, Female 2 Gastrointestinal Neoplasms 2 Fallopian Tube Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2

Interventions

Exercise 6 salicylhydroxamic acid 2 High-Intensity Interval Training 2 Echocardiography 2 sacubitril and valsartan sodium hydrate drug combination 1 mitoquinone 1 epicatechin gallate 1 candesartan 1 Therapeutics 1 Secondary Prevention 1 Restraint, Physical 1 Rehabilitation 1 Proton Therapy 1 Proteins 1 Palliative Care 1 Methods 1 Medical History Taking 1 Magnetic Resonance Spectroscopy 1 Laser-Doppler Flowmetry 1 Ivabradine 1 Heart Rate 1 Heart Function Tests 1 Exercise Test 1 Electrocardiography 1 Echocardiography, Stress 1 Blood Pressure 1 Blood Cell Count 1 Biomarkers 1 Anthropometry 1 Anthracyclines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04598646 2025-12-03

HIMALAYAS-P

University Health Network, Toronto

Phase NA Completed

Behavior, Heart Failure, Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡